Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A molecular dynamics simulation of the human lysozyme - camelid VHH HL6 antibody system.

International journal of molecular sciences - 17 Apr 2009

Su Zhi-Yuan, Wang Yeng-Tseng

Abstract excerpt

Amyloid diseases such as Alzheimer's and thrombosis are characterized by an aberrant assembly of specific proteins or protein fragments into fibrils and plaques that are deposited in various tissues and organs. The single-domain fragment of a camelid antibody was reported to be able to combat against wild-type human lysozyme for inhibiting in-vitro aggregations of the amyloidogenic variant (D67H). The present...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Databases, Protein
Share to Hydrogen Bonding

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Molecular Dynamics Simulation

Share to Muramidase

Share to Mutation

Share to Nanotechnology

Share to Protein Structure, Tertiary

Source

Open in PubMed Open full text

Identifiers

PMID: 19468335
DOI: 10.3390/ijms10041719
PMCID: PMC2680643

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A molecular dynamics simulation of the human lysozyme - camelid VHH HL6 antibody system.PMID 19468335Read ↗

Probing the stability-limiting regions of an antibody single-chain variable fragment: a molecular dynamics simulation studySemantic proximity Read ↗

Engineering a Camelid Antibody Fragment That Binds to the Active Site of Human Lysozyme and Inhibits Its Conversion into Amyloid FibrilsSemantic proximity Read ↗

A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme.Semantic proximity Read ↗

Lessons learned from merging wet lab experiments with molecular simulation to improve mAb humanization.Semantic proximity Read ↗

A Simple Analysis of the Second (Extra) Disulfide Bridge of VHHs.Semantic proximity Read ↗

The role of amino acid sequence in the self-association of therapeutic monoclonal antibodies: insights from coarse-grained modeling.Semantic proximity Read ↗

Functional Divergence in the Affinity and Stability of Non-Canonical Cysteines and Non-Canonical Disulfide Bonds: Insights from a VHH and VNAR Study.Semantic proximity Read ↗

Mitigation of reversible self-association and viscosity in a human IgG1 monoclonal antibody by rational, structure-guided Fv engineeringSemantic proximity Read ↗

Site-specific hydrogen exchange of proteins: insights into the structures of amyloidogenic intermediates.Semantic proximity Read ↗

A single disulfide bond disruption in the β3 integrin subunit promotes thiol/disulfide exchange, a molecular dynamics study.Semantic proximity Read ↗

A Comprehensive Analysis of Novel Disulfide Bond Introduction Site into the Constant Domain of Human FabSemantic proximity Read ↗

Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.